arrow
Y

Yan-Shen Shan

National Cheng Kung University Hospital
H指数:41
被引数:7,630

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tackling similarities and differences in global practice guidelines for gastric cancer: a review on the latest Taiwan guidelines with Asia-Pacific, European and US guidelines

探讨全球胃癌实践指南中的异同:对最新台湾指南与亚太、欧洲和美国指南的综述

2026-05-180
OA
SLOG versus Modified FOLFIRINOX as First-Line Treatment for Advanced Pancreatic Cancer: A Randomized Phase II Trial (TCOG T5217)

SLOG与改良FOLFIRINOX作为晚期胰腺癌一线治疗的比较:一项随机II期临床试验(TCOG T5217)

2026-01-110
PRE
Second-line 5-FU plus nanoliposomal irinotecan versus FOLFOX/XELOX in metastatic pancreatic cancer after gemcitabine–nab-paclitaxel failure: a propensity score-matched analysis

二线5-FU联合纳米脂质体伊立替康与FOLFOX/XELOX方案对比:在吉西他滨–白蛋白结合型紫杉醇治疗失败后的转移性胰腺癌中的倾向性评分匹配分析

2025-11-070
OAAI
Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study—TCOG T1214 study

台湾地区胃肠胰神经内分泌新生物的临床结局:一项多中心登记研究—TCOG T1214研究

Cancer
IF5.1
2025-08-200
OAAI
Macrophage activation determines muscle wasting in pancreatic cancer

巨噬细胞活化决定胰腺癌中的肌肉消耗

2025-05-290
OAAI